Extracorporeal membrane oxygenation (ECMO) assists cardiopulmonary functions outside the body. Based on the location of drainage and reinfusion there are three different types of extracorporeal membrane oxygenation system which are arteriovenous, venoarterial, and venovenous. Whereas, on the bases of age, ECMO systems are classified into neonatal, pediatric and adult. . The location of drainage and reinfusion port of cannulas determines the modality of the ECMO system. If drainage and reinfusion both are from central veins it is referred as venovenous ECMO or if it is from vein to artery it is referred to as venoarterial ECMO. ECMO is helpful for people who are very ill with conditions of the lungs and heart, or who are awaiting for or recovering from a heart transplant. It may be used when other life support measures do not work. ECMO does not treat or cure a disease, but can assist the body temporarily when it is not able to provide the tissues with enough oxygen.

Growing number of congenital heart defects, increase demand for ECMO. For instance, according to American Heart Association, approximately 40,000 infants are born with a congenital heart defect in U.S. each year and around 2 to 3 million individuals are living with a congenital heart defect.

Market Dynamics

Growth of ECMO market is due to factors such as increasing prevalence of cardiovascular and chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), occupational lung disease or pulmonary hypertension. For instance, according to data published by the World Health Organization, in May 2022, chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019.

Key features of the study:

• This report provides in-depth analysis of the global extracorporeal membrane oxygenation system market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global extracorporeal membrane oxygenation system market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic, Getinge AB, LivaNova PLC, Terumo Corporation, XENIOS AG, OriGen Biomedical, EUROSETS  NIPRO, and MicroPort Scientific Corporation 
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global extracorporeal membrane oxygenation system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracorporeal membrane oxygenation system market

Detailed Segmentation:

• Global Extracorporeal Membrane Oxygenation System Market, By Modality:
  • Arteriovenous
  • Venoarteial 
  • Venovenous 
• Global Extracorporeal Membrane Oxygenation System Market, By Application:
  • Extracorporeal cardiopulmonary resuscitation
  • Cardiac
  • Respiratory
• Global Extracorporeal Membrane Oxygenation System Market, By Age Group:
  • Neonatal
  • Pediatric
  • Adults
• Global Extracorporeal Membrane Oxygenation System Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • Medtronic
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Getinge AB
  • LivaNova PLC
  • Terumo Corporation
  • XENIOS AG
  • OriGen Biomedical
  • EUROSETS
  • NIPRO
  • MicroPort Scientific Corporation

 “*” marked represents similar segmentation in other categories in the respective section.